Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Scheithauer

Showing results (781-790 of 856) with videos related to

Pageof 86
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2002
Risk of cancer among relatives of patients with gliomaBrian P O'Neill, Hannes Blondal, Ping Yang, et al.
British Journal of Cancer|May 14, 1998
Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinomaW Scheithauer, G V Kornek, A Marczell, et al.
Cancer|February 15, 1997
Pituitary carcinoma: a clinicopathologic study of 15 casesP J Pernicone, B W Scheithauer, T J Sebo, et al.
Neuro-Oncology|June 27, 2002
Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomasHiroko Kuriyama, Kathleen R Lamborn, Judith R O'Fallon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomasJ S Smith, A Perry, T J Borell, et al.
Journal of Neuro-Oncology|December 11, 2008
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group resultsMarta Santisteban, Jan C Buckner, Joel M Reid, et al.
Journal of Neuro-Oncology|January 1, 1995
Phase II study of amonafide in patients with recurrent gliomaR Levitt, J C Buckner, T L Cascino, et al.
Plos Medicine|February 20, 2009
Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patientNinette Amariglio, Abraham Hirshberg, Bernd W Scheithauer, et al.
Clinical Neuropathology|April 5, 2005
Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumorsT A Gaffey, B W Scheithauer, R W Leech, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 26, 1998
Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patientsI Virgolini, I Szilvasi, A Kurtaran, et al.
Pageof 86

Showing results (781-790 of 856) with videos related to

Sort By:
Pageof 86
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2002
Risk of cancer among relatives of patients with gliomaBrian P O'Neill, Hannes Blondal, Ping Yang, et al.
British Journal of Cancer|May 14, 1998
Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinomaW Scheithauer, G V Kornek, A Marczell, et al.
Cancer|February 15, 1997
Pituitary carcinoma: a clinicopathologic study of 15 casesP J Pernicone, B W Scheithauer, T J Sebo, et al.
Neuro-Oncology|June 27, 2002
Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomasHiroko Kuriyama, Kathleen R Lamborn, Judith R O'Fallon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomasJ S Smith, A Perry, T J Borell, et al.
Journal of Neuro-Oncology|December 11, 2008
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group resultsMarta Santisteban, Jan C Buckner, Joel M Reid, et al.
Journal of Neuro-Oncology|January 1, 1995
Phase II study of amonafide in patients with recurrent gliomaR Levitt, J C Buckner, T L Cascino, et al.
Plos Medicine|February 20, 2009
Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patientNinette Amariglio, Abraham Hirshberg, Bernd W Scheithauer, et al.
Clinical Neuropathology|April 5, 2005
Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumorsT A Gaffey, B W Scheithauer, R W Leech, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 26, 1998
Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patientsI Virgolini, I Szilvasi, A Kurtaran, et al.
Pageof 86